VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price traded up 4.8% during mid-day trading on Tuesday . The stock traded as high as C$0.22 and last traded at C$0.22. 30,500 shares were traded during mid-day trading, a decline of 69% from the average session volume of 98,865 shares. The stock had previously closed at C$0.21.
VentriPoint Diagnostics Trading Up 4.8 %
The company has a current ratio of 2.06, a quick ratio of 6.67 and a debt-to-equity ratio of 32.61. The firm has a market capitalization of C$34.50 million, a P/E ratio of -7.33 and a beta of 0.39. The business has a 50 day moving average of C$0.25 and a 200-day moving average of C$0.24.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- What Does a Stock Split Mean?
- Silicon Motion Proves That AI in Motion Stays in Motion
- Basic Materials Stocks Investing
- Undervalued UnitedHealth Group Won’t Be For Long
- How to Invest in Insurance Companies: A Guide
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
